Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 2: effects of substitutions on pharmacological activity.
Wei-Jie Fang, Marco A Bennett, Thomas F Murray, Jane V Aldrich
Index: Biopolymers 96(1) , 103-10, (2011)
Full Text: HTML
Abstract
Arodyn (Ac[Phe¹,²,³,Arg⁴,D-Ala⁸]Dyn A(1-11)NH₂) is an acetylated dynorphin A (Dyn A) analog that is a potent and selective κ opioid receptor antagonist (Bennett et al., J Med Chem 2002, 45, 5617), and its analog [NMePhe¹]arodyn shows even higher affinity and selectivity for κ opioid receptors (Bennett et al., J Pept Res 2005, 65, 322). However, the latter compound is prone to deletion of the Ac-NMePhe moiety from the N-terminus of the peptide during acidic cleavage as described in the accompanying paper. Several stable analogs of [NMePhe¹]arodyn and [NMePhe¹,Trp³]arodyn where the acetyl group was substituted with a heteroatom-containing group were evaluated for their opioid receptor affinity, selectivity, and efficacy. Methoxycarbonyl derivatives exhibited the highest κ opioid receptor affinity among the analogs. Additional [CH₃OCO-NMePhe¹]arodyn analogs where position 3 was substituted with other aromatic or nonaromatic residues were also evaluated for κ receptor affinity, selectivity, and efficacy. [CH₃OCO-NMePhe¹]arodyn has similar κ opioid receptor affinity as [NMePhe¹]arodyn, retains high κ opioid receptor selectivity, and is a potent κ opioid receptor antagonist.
Related Compounds
Related Articles:
2012-05-07
[Chemistry 18(19) , 5832-6, (2012)]
2003-10-29
[J. Am. Chem. Soc. 125(43) , 13046-51, (2003)]
2001-11-20
[Biochemistry 40(46) , 14047-52, (2001)]
1998-09-29
[Biochemistry 37(39) , 13507-15, (1998)]
2005-01-25
[Brain Res. 1032(1-2) , 94-103, (2005)]